Immediate Impact
5 from Science/Nature 66 standout
Citing Papers
Therapeutic advances in rheumatoid arthritis
2024 Standout
The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout
Works of Pascal Espié being referenced
First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody
2019
Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Pascal Espié | 103 | 105 | 39 | 134 | 108 | 21 | 601 | |
| Kyoko Matsuguma | 112 | 39 | 23 | 84 | 54 | 16 | 629 | |
| Ingrid Fricke-Galindo | 108 | 80 | 9 | 138 | 95 | 36 | 663 | |
| Vincent Yip | 86 | 64 | 38 | 108 | 66 | 24 | 637 | |
| Himanshu Naik | 169 | 205 | 83 | 39 | 55 | 34 | 720 | |
| Haiqing Dai | 122 | 64 | 56 | 134 | 43 | 23 | 696 | |
| Eugène Cox | 148 | 35 | 20 | 85 | 92 | 22 | 611 | |
| Ping He | 116 | 71 | 12 | 85 | 24 | 23 | 524 | |
| Muradiye Nacak | 125 | 33 | 7 | 78 | 33 | 28 | 580 | |
| James Hilbert | 105 | 107 | 27 | 51 | 46 | 37 | 700 | |
| Michael Heathman | 165 | 45 | 29 | 39 | 53 | 23 | 582 |
All Works
Loading papers...